Yinxia Chao
Singapore, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
PCSK9 inhibitors in neurodegenerative disorders: mechanisms, therapeutic potential, and clinical implications.
Journal: Translational neurodegeneration
Published: July 27, 2025
Blood and brain tissue RNA transcriptomics reveal six potential targets of Parkinson's disease: a meta-analysis.
Journal: Journal of advanced research
Published: May 20, 2025
Study protocol: The efficacy of mushroom to prevent cognitive decline in at-risk middle-aged adults and young-olds living in the community.
Journal: Frontiers in aging neuroscience
Published: March 06, 2025
Longitudinal quantification of serum SARS-CoV-2 neutralising antibodies, pro-inflammatory cytokines, NfL and GFAP before and after breakthrough COVID-19 infection in CNS neuroimmunological diseases: a prospective observational study.
Journal: Therapeutic advances in infectious disease
Published: February 03, 2025
A Systemic Review and Meta-Analysis of the Risk of Venous Thromboembolic Events in Parkinson's Patients.
Journal: European journal of neurology
Published: November 30, 2024
Transcriptomic imputation of genetic risk variants uncovers novel whole-blood biomarkers of Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: July 29, 2023
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore.
Journal: Journal of neurology
Published: December 21, 2022
Parkinson's Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1.
Journal: Cells
Published: April 09, 2022
From Trial to Implementation, Bringing Team-Based Learning Online-Duke-NUS Medical School's Response to the COVID-19 Pandemic.
Journal: Medical science educator
Published: August 25, 2020
Last Updated: 09/26/2026